BackCinCor Pharma Overview

CinCor Pharma Accounts Payable

Latest accounts payable for CINC: $2.6M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.59M
↓ 35.45% YoYΔ $-1.42M vs prior year quarter

Peer average

Loading

CinCor Pharma Accounts Payable History

Loading

CinCor Pharma vs. peers: Accounts Payable Comparison

Loading

CinCor Pharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CinCor Pharma (CINC) FAQ

As of the most recent data (September 2022), CINC shows a accounts payable of $2.6M. That compares with $4M in the prior-year period — down 35.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CINC's accounts payable is now $2.6M (was $4M) — a 35.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether CinCor Pharma is outperforming or lagging.

Tracking CINC's accounts payable over time shows whether CinCor Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6M That compares with $4M in the prior-year period — down 35.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has CinCor Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.6M) with ownership activity and broader fundamentals.